Myasthenia gravis with thymic epithelial tumour: A retrospective analysis of a Japanese database

European Journal of Cardio-thoracic Surgery

Volumn 49, Issue 5, 2016, Pages 1510-1515

  Nakajima, Jun ^a   Okumura, Meinoshin ^b   Yano, Motoki ^c   Date, Hiroshi ^d   Onuki, Takuya ^e   Haniuda, Masayuki ^f   Sano, Yoshifumi ^g   Yoshino, Ichiro ^h   Asamura, Hisao ⁱ   Yoshida, Kazuo ^j   Nagai, Kanji ^k   Yokoi, Kohei ^l   Miyoshi, Shinichiro ^m   Higashiyama, Masahiko ⁿ   Suzuki, Kenji ^o   Tsuchida, Masanori ^p   Haraguchi, Shuji ^q   Niwa, Hiroshi ^r   Kondo, Kazuya ^s   Horio, Hirotoshi ^t   Matsumura, Akihide ^u   Okamoto, Tatsuro ^v   Ikeda, Norihiko ^w   Tanaka, Fumihiro ^x   Maniwa, Yoshimasa ^y   Onuki, Takamasa ^z   Suzuki, Makoto ^aa   Nagayasu, Takeshi ^ab   Iwasaki, Akinori ^ac   Suehisa, Hiroshi ^ad   Ohde, Yasuhisa ^ae   Kondo, Keishi ^af   more..

^a UNIVERSITY OF TOKYO   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c NAGOYA CITY UNIVERSITY   (Japan)

^d KYOTO UNIVERSITY   (Japan)

^e TSUCHIURA KYODO GENERAL HOSPITAL   (Japan)

^f AICHI MEDICAL UNIVERSITY   (Japan)

^g EHIME UNIVERSITY   (Japan)

^h CHIBA UNIVERSITY   (Japan)

ⁱ NATIONAL CANCER CENTER HOSPITAL   (Japan)

^j SHINSHU UNIVERSITY   (Japan)

^k NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^l NAGOYA UNIVERSITY   (Japan)

^m OKAYAMA UNIVERSITY   (Japan)

ⁿ OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^o JUNTENDO UNIVERSITY   (Japan)

^p NIIGATA UNIVERSITY   (Japan)

^q NIPPON MEDICAL SCHOOL   (Japan)

^r SEIREI MIKATAHARA GENERAL HOSPITAL   (Japan)

^s UNIVERSITY OF TOKUSHIMA   (Japan)

^t TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^u NATIONAL HOSPITAL ORGANIZATION KINKI CHUO CHEST MEDICAL CENTER   (Japan)

^v KYUSHU UNIVERSITY   (Japan)

^w TOKYO MEDICAL UNIVERSITY   (Japan)

^x UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^y KOBE UNIVERSITY   (Japan)

^z TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^aa KUMAMOTO UNIVERSITY   (Japan)

^ab NAGASAKI UNIVERSITY   (Japan)

^ac FUKUOKA UNIVERSITY   (Japan)

^ad NATIONAL HOSPITAL ORGANIZATION SHIKOKU CANCER CENTER   (Japan)

^ae SHIZUOKA CANCER CENTER   (Japan)

^af HOKKAIDO CANCER CENTER   (Japan)

more..

Author keywords

Myasthenia gravis; Survival analysis; Thymectomy; Thymic carcinoma; Thymoma

Indexed keywords

CHOLINERGIC RECEPTOR ANTIBODY; CORTICOSTEROID;

ADULT; ANTIBODY TITER; ARTICLE; CANCER PROGNOSIS; CORTICOSTEROID THERAPY; DISEASE SEVERITY; FEMALE; HUMAN; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; MALE; MORTALITY RATE; MULTICENTER STUDY; MYASTHENIA GRAVIS; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; REFERENCE DATABASE; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; THYMECTOMY; THYMUS CANCER; TREATMENT OUTCOME; TUMOR VOLUME; AGED; COMPLICATION; JAPAN; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; PROGNOSIS; THYMUS NEOPLASMS;

ADULT; AGED; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; NEOPLASMS, GLANDULAR AND EPITHELIAL; PROGNOSIS; RETROSPECTIVE STUDIES; THYMECTOMY; THYMUS NEOPLASMS;

EID: 84965117190     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1093/ejcts/ezv380     Document Type: Article

References (25)

1. Kondo K, Monden Y. Thymoma and myasthenia gravis: a clinical study of 1,089 patients from Japan. Ann Thorac Surg 2005;79:219-24.
2. Filosso PL, Venuta F, Oliaro A, Ruffini E, Rendina EA, Margaritora S et al. Thymoma and inter-relationships between clinical variables: a multicentre study in 537 patients. Eur J Cardiothorac Surg 2014;45:1020-7.
3. Ströbel P, Marx A, Zettl A, Müller-Hermelink HK. Thymoma and thymic carcinoma: an update of the WHO Classification 2004. Surg Today 2005; 35:805-11.
4. Masaoka A, Monden Y, Nakahara K, Tanioka T. Follow-up study of thymomas with special reference to their clinical stages. Cancer 1981;48:2485-92.
5. Jaretzki A III, Barohn RJ, Ernstoff RM, Kaminski HJ, Keesey JC, Penn AS et al. Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the myasthenia gravis Foundation of America. Neurology 2000;55:16-23.
6. Kanda Y. Free statistical software: EZR (Easy R) on R commander. http:// www.jichi.ac.jp/saitama-sct/SaitamaHP.files/statmedEN.html (21 September 2015, date last accessed).
7. Papatestas AE, Genkins G, Kornfeld P, Eisenkraft JB, Fagerstrom RP, Pozner J et al. Effects of thymectomy in myasthenia gravis. Ann Surg 1987;206: 79-88.
8. Monden Y, Uyama T, Nakahara K, Fujii Y, Hashimoto J, Ohno K et al. Clinical characteristics and prognosis of myasthenia gravis with other autoimmune diseases. Ann Thorac Surg 1986;41:189-92.
9. Drachman DB. Myasthenia gravis. N Engl J Med. 1994;330:1797-810.
10. Phillips LH. The epidemiology of myasthenia gravis. Ann N Y Acad Sci 2003;998:407-12.
11. Mao ZF, Mo XA, Qin C, Lai YR, Hackett ML. Incidence of thymoma in myasthenia gravis: a systematic review. J Clin Neurol 2012;8:161-9.
12. Ruffini E, Detterbeck F, Van Raemdonck D, Rocco G, Thomas P, Weder W et al. Tumours of the thymus: a cohort study of prognostic factors from the European Society of Thoracic Surgeons database. Eur J Cardiothorac Surg 2014;46:361-8.
13. Liu HC, Hsu WH, Chen YJ, Chan YJ, Wu YC, Huang BS et al. Primary thymic carcinoma. Ann Thorac Surg 2002;73:1076-81.
14. Filosso PL, Guerrera F, Rendina AE, Bora G, Ruffini E, Novero D et al. Outcome of surgically resected thymic carcinoma: a multicenter experience. Lung Cancer 2014;83:205-10.
15. Okumura M, Miyoshi S, Fujii Y, Takeuchi Y, Shiono H, Inoue M et al. Clinical and functional significance of WHO classification on human thymic epithelial neoplasms: a study of 146 consecutive tumors. Am J Surg Pathol 2001;25:103-10.
16. Sakamoto M, Murakawa T, Konoeda C, Inoue Y, Kitano K, Sano A et al. Survival after extended thymectomy for thymoma. Eur J Cardiothorac Surg 2012;41:623-7.
17. Müller-Hermelink HK, Marx A, Geuder K, Kirchner T. The pathological basis of thymoma-associated myasthenia gravis. Ann N Y Acad Sci 1993; 681:56-65.
18. Shiono H, Roxanis I, Zhang W, Sims GP, Meager A, Jacobson LW et al. Scenarios for autoimmunization of T and B cells in myasthenia gravis. Ann N Y Acad Sci 2003;998:237-56.
19. Yu L, Zhang XJ, Ma S, Jing Y, Li F, Krasna MJ. Different characteristics of thymomas with and withoutmyasthenia gravis. Ann Surg Oncol 2012;19:94-8.
20. Lucchi M, Ricciardi R, Melfi F, Duranti L, Basolo F, Palmiero G et al. Association of thymoma and myasthenia gravis: oncological and neurological results of the surgical treatment. Eur J Cardiothorac Surg 2009;35:812-6.
21. Namba T, Brunner NG, Grob D. Myasthenia gravis in patients with thymoma, with particular reference to onset after thymectomy. Medicine (Baltimore) 1978;57:411-33.
22. Nakajima J, Murakawa T, Fukami T, Sano A, Takamoto S, Ohtsu H. Postthymectomy myasthenia gravis: relationship with thymoma and antiacetylcholine receptor antibody. Ann Thorac Surg 2008;86:941-5.
23. Okumura M, Ohta M, Tateyama H, Nakagawa K, Matsumura A, Maeda H et al. The World Health Organization histologic classification system reflects the oncologic behavior of thymoma: a clinical study of 273 patients. Cancer 2002;94:624-32.
24. Wilkins EW Jr, Edmunds LH Jr, Castleman B. Cases of thymoma at the Massachusetts General Hospital. J Thorac Cardiovasc Surg 1966;52: 322-30.
25. Loach AB, Young AC, Spalding JM, Smith AC. Postoperative management after thymectomy. Br Med J 1975;1(5953):309-12.